SynopsisThymosins can enhance body immunity and are mainly used in the treatment of hepatitis and tumors. Thymosins mainly include Thymosin, Thymopentin and Thymosin α1. Thymosin α1 is a high-end thymosin. Clinical trials suggest it may be useful in cystic fibrosis, s.....
SynopsisThe global Salmon Calcitonin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Salmon Calcitonin is estimated to increase from .....
SynopsisGonadorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) which is used in fertility medicine and to treat amenorrhea and hypogonadism. It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release.....
SynopsisTerlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help. The global Terlipressin market was valued at US$ million in 2023 and is anticipate.....
SynopsisArgireline is a natural peptide which is a unique, effective anti wrinkle peptide that was proven as first alternative to Botulinum Toxin. The global Argireline market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, wit.....
SynopsisThe global Acetyl Hexapeptide-38 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Acetyl Hexapeptide-38 is estimated to increa.....
SynopsisArgireline is a common ingredient in many skincare products. Argireline Cream is a kind of skin care product, a painless alternative to Botox for eliminating the appearance of wrinkles. It smooths away fine lines and leaves the skin feeling soft and rejuvenate.....
SynopsisAtosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. The global Atosiban market was valued at US$ million in 2023 and is anticipated to rea.....
SynopsisThe global Vasopressin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The main sound field manufacturers of vasopressin are Endo, Ferring, Fresenius K.....
SynopsisThe global Laryngeal Cancer Therapeutics market was valued at US$ 2058.6 million in 2023 and is anticipated to reach US$ 3144.9 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030. North American market for Laryngeal Cancer Th.....
